Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Florence Wong

Showing results (61-70 of 207) with videos related to

Pageof 21
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|October 4, 2019
Pathways of hepatic and renal damage through non-classical activation of the renin-angiotensin system in chronic liver diseaseGiovanni Sansoè, Manuela Aragno, Florence Wong
JBI Library of Systematic Reviews|November 8, 2016
Factors influencing health-related quality of life in patients with an implantable cardioverter defibrillator: A systematic reviewFlorence Wong, Janet Sit, Eliza Wong
Hepatology (Baltimore, Md.)|February 1, 2021
COVID-19 and Liver Cirrhosis: Focus on the Nonclassical Renin-Angiotensin System and Implications for TherapyGiovanni Sansoè, Manuela Aragno, Florence Wong
Hepatology (Baltimore, Md.)|July 9, 2004
Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndromeFlorence Wong, Lavinia Pantea, Kenneth Sniderman
Medgenmed : Medscape General Medicine|March 19, 2005
Renal dysfunction in cirrhosis: diagnosis, treatment and preventionElaine Yeung, Elaine Yong, Florence Wong
Canadian Liver Journal|February 23, 2026
A retrospective study on the use of albumin in the management of complications of decompensated cirrhosis from a major teaching hospital in CanadaMai Kilany, Neha Tiwari, Florence Wong
Gut|August 28, 2009
Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatmentFlorence Wong, Nilima Raina, Robert Richardson
Journal of Hepatology|July 20, 2021
Reply to: Correspondence on "Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure"Florence Wong, Salvatore Piano, Paolo Angeli
Alimentary Pharmacology & Therapeutics|December 8, 2022
Editorial: terlipressin in patients with ACLF grade 3-too late? Authors' replyFlorence Wong, S Chris Pappas, Khurram Jamil
Clinics in Liver Disease|September 30, 2019
Ascites and Hepatorenal SyndromeDanielle Adebayo, Shuet Fong Neong, Florence Wong
Pageof 21

Showing results (61-70 of 207) with videos related to

Sort By:
Pageof 21
Liver International : Official Journal of the International Association for the Study of the Liver|October 4, 2019
Pathways of hepatic and renal damage through non-classical activation of the renin-angiotensin system in chronic liver diseaseGiovanni Sansoè, Manuela Aragno, Florence Wong
JBI Library of Systematic Reviews|November 8, 2016
Factors influencing health-related quality of life in patients with an implantable cardioverter defibrillator: A systematic reviewFlorence Wong, Janet Sit, Eliza Wong
Hepatology (Baltimore, Md.)|February 1, 2021
COVID-19 and Liver Cirrhosis: Focus on the Nonclassical Renin-Angiotensin System and Implications for TherapyGiovanni Sansoè, Manuela Aragno, Florence Wong
Hepatology (Baltimore, Md.)|July 9, 2004
Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndromeFlorence Wong, Lavinia Pantea, Kenneth Sniderman
Medgenmed : Medscape General Medicine|March 19, 2005
Renal dysfunction in cirrhosis: diagnosis, treatment and preventionElaine Yeung, Elaine Yong, Florence Wong
Canadian Liver Journal|February 23, 2026
A retrospective study on the use of albumin in the management of complications of decompensated cirrhosis from a major teaching hospital in CanadaMai Kilany, Neha Tiwari, Florence Wong
Gut|August 28, 2009
Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatmentFlorence Wong, Nilima Raina, Robert Richardson
Journal of Hepatology|July 20, 2021
Reply to: Correspondence on "Clinical features and evolution of bacterial infection-related acute-on-chronic liver failure"Florence Wong, Salvatore Piano, Paolo Angeli
Alimentary Pharmacology & Therapeutics|December 8, 2022
Editorial: terlipressin in patients with ACLF grade 3-too late? Authors' replyFlorence Wong, S Chris Pappas, Khurram Jamil
Clinics in Liver Disease|September 30, 2019
Ascites and Hepatorenal SyndromeDanielle Adebayo, Shuet Fong Neong, Florence Wong
Pageof 21